From government site

https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00772

Manufacturer:
Authorization holder: AstraZeneca Canada Inc.

Drug Identification Numbers issued:
DIN 02510847 - 5 x 1010 VP / 0.5mL, solution, intramuscular (vial contains 10 doses of 0.5 mL)
DIN 02511444 - 5 x 1010 VP / 0.5mL, solution, intramuscular (vial contains 8 doses of 0.5 mL)

Prescription status:
AstraZeneca COVID-19 Vaccine is a Schedule D drug.

Date filed:
2020-10-01

Contact:
Office of Regulatory Affairs - Biologic and Radiopharmaceutical Drugs Directorate (ORA-BRDD)

 Does not seem to have any special requirements or restrictions